Drug: |
PLX3397 (PLX108-01) |
|||
---|---|---|---|---|
Trial: |
Safety Study of PLX108-01 in Patients With Solid Tumors |
|||
Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
Comprehensive Cancer Centers of Nevada3730 S. Eastern Avenue |
Principal Investigator: |
Fadi Braiteh, MD, CPI |
---|---|
Contact: |
Muhammad Khan, MD 281-863-6538 muhammad.khan@mckesson.com |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Comprehensive Cancer Centers of Nevada Website: |
http://www.cccnevada.com/clinical-research/active-trials/ |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.